GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Turk Ilac ve Serum Sanayi (IST:TRILC) » Definitions » Gross Margin %

Turk Ilac ve Serumnayi (IST:TRILC) Gross Margin % : 15.83% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Turk Ilac ve Serumnayi Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Turk Ilac ve Serumnayi's Gross Profit for the three months ended in Sep. 2023 was ₺69 Mil. Turk Ilac ve Serumnayi's Revenue for the three months ended in Sep. 2023 was ₺436 Mil. Therefore, Turk Ilac ve Serumnayi's Gross Margin % for the quarter that ended in Sep. 2023 was 15.83%.

Warning Sign:

Turk Ilac ve Serum Sanayi gross margin has been in long-term decline. The average rate of decline per year is -20.7%.


The historical rank and industry rank for Turk Ilac ve Serumnayi's Gross Margin % or its related term are showing as below:

IST:TRILC' s Gross Margin % Range Over the Past 10 Years
Min: 17.9   Med: 47.85   Max: 64.23
Current: 21.8


During the past 6 years, the highest Gross Margin % of Turk Ilac ve Serumnayi was 64.23%. The lowest was 17.90%. And the median was 47.85%.

IST:TRILC's Gross Margin % is ranked worse than
86.31% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.51 vs IST:TRILC: 21.80

Turk Ilac ve Serumnayi had a gross margin of 15.83% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Turk Ilac ve Serumnayi was -20.70% per year.


Turk Ilac ve Serumnayi Gross Margin % Historical Data

The historical data trend for Turk Ilac ve Serumnayi's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turk Ilac ve Serumnayi Gross Margin % Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Margin %
Get a 7-Day Free Trial 57.23 46.02 49.67 17.90 24.97

Turk Ilac ve Serumnayi Quarterly Data
Dec17 Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.09 29.44 17.25 32.55 15.83

Competitive Comparison of Turk Ilac ve Serumnayi's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Turk Ilac ve Serumnayi's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's Gross Margin % falls into.



Turk Ilac ve Serumnayi Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Turk Ilac ve Serumnayi's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=208.1 / 833.438
=(Revenue - Cost of Goods Sold) / Revenue
=(833.438 - 625.338) / 833.438
=24.97 %

Turk Ilac ve Serumnayi's Gross Margin for the quarter that ended in Sep. 2023 is calculated as


Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=69 / 435.882
=(Revenue - Cost of Goods Sold) / Revenue
=(435.882 - 366.896) / 435.882
=15.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Turk Ilac ve Serumnayi  (IST:TRILC) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Turk Ilac ve Serumnayi had a gross margin of 15.83% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Turk Ilac ve Serumnayi Gross Margin % Related Terms

Thank you for viewing the detailed overview of Turk Ilac ve Serumnayi's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Turk Ilac ve Serumnayi (IST:TRILC) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Bügduz Mah. Enver Pasa Cad., No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.

Turk Ilac ve Serumnayi (IST:TRILC) Headlines

No Headlines